Going global: Supporting the expansion of Taiwan’s biotech ecosystem

Learn more about the development of Taiwanese biotech into the force it is today, its unique benefits and advantages, and what the industry must do to expand its capabilities both regionally and globally. Capture the key takeaways from a recent discussion hosted by Citeline and featuring experts from Novotech.

• The evolution of Taiwan’s biotech ecosystem and Taiwan’s current clinical trial environment
• The unique advantages of Taiwan’s biotech ecosystem
• Considering Australia’s strengths as a clinical research base for Asia
• Common challenges of moving from early- to later-stage studies
• Expanding globally by leveraging CRO partnerships
• Long-term mindset and global vision: keys to future success and expansion